147 related articles for article (PubMed ID: 10655786)
1. [Chemical control of cell differentiation of human myeloleukemia K562 cell line].
Koiso Y; Nakajima O; Matsumura D; Fujimoto Y; Hashimoto Y
Yakugaku Zasshi; 2000 Jan; 120(1):104-12. PubMed ID: 10655786
[TBL] [Abstract][Full Text] [Related]
2. Modification by heme oxygenase inhibitor, tin protoporphyrin, of cellular differentiation of human myeloid leukemia K562 cell line.
Koiso Y; Fujimoto Y; Matsumura D; Nakajima O; Hashimoto Y
Biol Pharm Bull; 1999 Apr; 22(4):439-40. PubMed ID: 10328571
[TBL] [Abstract][Full Text] [Related]
3. Hemin-induced erythroid differentiation of human myeloleukemia K562 cell line and its modification by bioresponse modifiers.
Nakajima O; Iwasaki S; Hashimoto Y
Cell Mol Biol (Noisy-le-grand); 1997 Feb; 43(1):115-34. PubMed ID: 9074796
[TBL] [Abstract][Full Text] [Related]
4. Possible involvement of retinoid-like cofactor in serum in hemin/protoporphyrin-IX-induced differentiation of human leukemia K562 cells.
Nakajima O; Kagechika H; Shudo K; Hashimoto Y; Iwasaki S
Biochem Biophys Res Commun; 1995 Jan; 206(3):1003-10. PubMed ID: 7832789
[TBL] [Abstract][Full Text] [Related]
5. Possible involvement of peripheral-type benzodiazepine receptors in erythroid differentiation of human leukemia cell line, K562.
Nakajima O; Hashimoto Y; Iwasaki S
Biol Pharm Bull; 1995 Jun; 18(6):903-6. PubMed ID: 7550130
[TBL] [Abstract][Full Text] [Related]
6. Involvement of PKC in TPA-potentiated apoptosis induction during hemin-mediated erythroid differentiation in K562 cells.
Chou CC; Hsu CY
Naunyn Schmiedebergs Arch Pharmacol; 2009 Jan; 379(1):1-9. PubMed ID: 18758751
[TBL] [Abstract][Full Text] [Related]
7. Increase in the chemically-induced differentiation of human leukemia cell lines by tubulin disruptors.
Nakajima O; Sugishita Y; Hashimoto Y; Iwasaki S
Biol Pharm Bull; 1994 May; 17(5):742-4. PubMed ID: 7920447
[TBL] [Abstract][Full Text] [Related]
8. Enhancement by retinoid of hemin-induced differentiation of human leukemia K562 cell line.
Nakajima O; Hashimoto Y; Iwasaki S
FEBS Lett; 1993 Sep; 330(1):81-4. PubMed ID: 8370465
[TBL] [Abstract][Full Text] [Related]
9. Induction of erythroid differentiation of K562 human leukemic cells by herbimycin A, an inhibitor of tyrosine kinase activity.
Honma Y; Okabe-Kado J; Hozumi M; Uehara Y; Mizuno S
Cancer Res; 1989 Jan; 49(2):331-4. PubMed ID: 2910452
[TBL] [Abstract][Full Text] [Related]
10. Erythroid differentiation-inducing activity of protoporphyrin IX and its analogs on human leukemia K562 cell line.
Nakajima O; Hashimoto Y; Iwasaki S
Biochem Biophys Res Commun; 1994 Jan; 198(2):720-7. PubMed ID: 8297384
[TBL] [Abstract][Full Text] [Related]
11. Effect of differentiation-inducing agents on oncogene expression in a chronic myelogenous leukemia cell line.
Eisbruch A; Blick M; Evinger-Hodges MJ; Beran M; Andersson B; Gutterman JU; Kurzrock R
Cancer; 1988 Sep; 62(6):1171-8. PubMed ID: 3044574
[TBL] [Abstract][Full Text] [Related]
12. Iron protoporphyrin IX (hemin) but not tin or zinc protoporphyrin IX can stimulate gene expression in K562 cells from enhancer elements containing binding sites for NF-E2.
Palma JF; Gao X; Lin CH; Wu S; Solomon WB
Blood; 1994 Aug; 84(4):1288-97. PubMed ID: 8049443
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of transglutaminase 2 accelerates the erythroid differentiation of human chronic myelogenous leukemia K562 cell line through PI3K/Akt signaling pathway.
Kang SK; Lee JY; Chung TW; Kim CH
FEBS Lett; 2004 Nov; 577(3):361-6. PubMed ID: 15556610
[TBL] [Abstract][Full Text] [Related]
14. Erythroid properties of K562 cells. Effect of hemin, butyrate and TPA induction.
Villeval JL; Pelicci PG; Tabilio A; Titeux M; Henri A; Houesche F; Thomopoulos P; Vainchenker W; Garbaz M; Rochant H; Breton-Gorius J; Edwards PA; Testa U
Exp Cell Res; 1983 Jul; 146(2):428-35. PubMed ID: 6575918
[TBL] [Abstract][Full Text] [Related]
15. Role of ERK activation in growth and erythroid differentiation of K562 cells.
Woessmann W; Mivechi NF
Exp Cell Res; 2001 Apr; 264(2):193-200. PubMed ID: 11262176
[TBL] [Abstract][Full Text] [Related]
16. Differential expression changes in K562 cells during the hemin-induced erythroid differentiation and the phorbol myristate acetate (PMA)-induced megakaryocytic differentiation.
Huo XF; Yu J; Peng H; Du ZW; Liu XL; Ma YN; Zhang X; Zhang Y; Zhao HL; Zhang JW
Mol Cell Biochem; 2006 Nov; 292(1-2):155-67. PubMed ID: 16786195
[TBL] [Abstract][Full Text] [Related]
17. Heme oxygenase-1 attenuates vascular remodeling following balloon injury in rat carotid arteries.
Tulis DA; Durante W; Peyton KJ; Evans AJ; Schafer AI
Atherosclerosis; 2001 Mar; 155(1):113-22. PubMed ID: 11223432
[TBL] [Abstract][Full Text] [Related]
18. ETV6 Regulates Hemin-Induced Erythroid Differentiation of K562 Cells through Mediating the Raf/MEK/ERK Pathway.
Li Z; Sun MZ; Lv X; Guo C; Liu S
Biol Pharm Bull; 2022; 45(3):250-259. PubMed ID: 35228392
[TBL] [Abstract][Full Text] [Related]
19. Downregulation of Wilms' tumor gene (WT1) is not a prerequisite for erythroid or megakaryocytic differentiation of the leukemic cell line K562.
Svedberg H; Chylicki K; Gullberg U
Exp Hematol; 1999 Jun; 27(6):1057-62. PubMed ID: 10378895
[TBL] [Abstract][Full Text] [Related]
20. Effects of the antisense myb expression on hemin- and erythropoietin-induced erythroid differentiation of K562 cells.
Kamano H; Tanaka T; Ohnishi H; Kubota Y; Ikeda K; Takahara J; Irino S; Ottalenghi S
Biochem Mol Biol Int; 1994 Aug; 34(1):85-92. PubMed ID: 7849628
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
